![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
February 28, 2020
February 28, 2020
This trial is evaluating maintenance nivolumab versus observation following intensity-modulated radiation therapy and cisplatin
January 14, 2020
Reflecting on key milestones in 2019: TMIST breast cancer screening trial continues to ramp up; NCORP grant renewal emphasizes screening, symptom control, and cancer care delivery research; new role for Dr. Al Benson; E1912's practice-changing trial results; update on Dr. Otis Brawley's efforts to form the Social Determinants of Health Working Group; EA launches the Comis Symposium
January 13, 2020
Lower chemoradiation doses may effectively treat early stage anal cancer while improving quality of life
January 13, 2020
January 13, 2020
January 14, 2020
January 14, 2020
November 1, 2019
Fall 2019 Group Meeting recap; new Group Meeting format; Comis Symposium; Dr. Otis Brawley to lead with the new Social Determinants of Health Working Group
November 1, 2019
This new trial seeks to define the optimal upfront treatment for an aggressive form of lymphoma
November 1, 2019
Dr. Edith Mitchell describes a current focus of the Health Equity Committee
November 1, 2019
Dr. Matthew Schabath discusses cancer disparities in the LGBTQ+ population